Pune, Maharashtra -- (SBWIRE) -- 06/22/2020 -- Manhattan, New York, Analytical Research Cognizance: The Pertussis Vaccine market is projected to witness momentous growth over the upcoming years due to a tremendous rise in demand due to the global COVID-19 pandemic. The report includes an in-depth, extensive study of this market in tandem with vital parameters that are likely to have an effect on the market commercialization matrix.
Pertussis vaccine is being used to treat cough. This vaccination only comes in tandem with other vaccines. Pertussis vaccine is recommended to all infants, pregnant women, children and teens. Children below seven years of age are given tetanus, diphtheria along with pertussis (DTaP) vaccine, while elder ones and adults receive diphtheria, tetanus and pertussis vaccine. Childhood vaccination is considered to be the best and most cost effective ways to maintain an environment free from pertussis. WHO recommends all children to be regularly vaccinated for pertussis. Globally, nearly 85 percent of children received DTP3 vaccine to defend them from various infectious diseases, according to WHO in 2015. In 2015, pertussis vaccine procurement by UNICEF reached 5.87 million doses for 18 territories and countries, of which Morocco, Egypt, Zimbabwe and Uzbekistan accounted for more than 80% of the total procurement made by UNICEF. Vaccines utilized for DTP are usually immunization drugs generally administered at a low age of two in order to produce immunity against DTP. Increase in demand for tetravalent combination vaccines has primarily contributed to the overall growth. The increased demand for this combination product has been led by funding from GAVI for DTP containing vaccines.
Request to sample for this research report@ https://www.arcognizance.com/enquiry-sample/1046649?utm_source=Sbwire&utm_medium=180406
Factors such as high birth rates, increased geriatric population, government programs, increased pertussis vaccination adoption, and health insurance and reimbursement scenario are expected to drive the pertussis vaccine demand worldwide. In 2015, 126 countries had at least reached 90 percent coverage of the diphtheria-tetanus-pertussis vaccine, according to WHO. On the other hand, factors such as vaccine injuries and adverse effects are likely to hinder the development of the global demand for pertussis vaccines. In 2015 in U.S., the federal Vaccine Injury Compensation Program filed 7 claims regarding deaths and injuries following pertussis vaccination for three deaths and four serious injuries.
The global pertussis vaccine industry is divided on the basis of product type, end-use, vaccine type and geography. Based on the product type, the global market is bifurcated into DTaP vaccine, Tdap vaccine. Based on vaccine type, the global pertussis vaccine market is divided into acellular vaccine, whole-cell vaccine. On the basis of end-use, the global pertussis vaccine market is segmented into hospitals, clinics, vaccine centers. Geographically, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa (MEA).
Some of the key players operating within the global Pertussis Vaccine market include Sanofi Pasteur, Seqirus, Astellas Pharma US, Inc. Merck Sharp & Dohme Corp., GlaxoSmithKline, Protein Sciences Corporation, Novartis AG among other noticeable players.
Access Complete Research Report@ https://www.arcognizance.com/report/2019-global-pertussis-vaccine-industry-research-report-and-forecast-2025-and-outlook?utm_source=Sbwire&utm_medium=180406
Some Points of TOC:
Chapter One: Market Introduction
Chapter Two: Executive Summary
Chapter Three: Global Pertussis Vaccine Market – Key Industry Dynamics
Chapter Four: Global Pertussis Vaccine Market – Analysis and Revenue Forecast, 2015-2025 – By Product Type
Chapter Five: Global Pertussis Vaccine Market – Analysis and Revenue Forecast, 2015-2025 – By Application
Chapter Six: Global Pertussis Vaccine Market – Analysis and Revenue Forecast, 2015-2025 – By End-Use
Chapter Seven: Global Pertussis Vaccine Market – Analysis and Revenue Forecast, 2015-2025 – By Region
Chapter Eight: North America Pertussis Vaccine Market – Analysis and Revenue Forecast, 2015-2025
Chapter Nine: Europe Pertussis Vaccine Market – Analysis and Revenue Forecast, 2015-2025
Chapter Ten: Asia-Pacific Pertussis Vaccine Market – Analysis and Revenue Forecast, 2015-2025
Chapter Eleven: Latin America Pertussis Vaccine Market – Analysis and Revenue Forecast, 2015-2025
Chapter Twelve: Middle East & Africa Pertussis Vaccine Market – Analysis and Revenue Forecast, 2015-2025
Chapter Thirteen: Competitive Analysis
Chapter Fourteen: Appendix
Chapter Fifteen: Research Conclusions
Contact Us:
Ranjeet Dengale
Director Sales
Analytical Research Cognizance
+1 (646) 403-4695, +91 90967 44448
sales@arcognizance.com
Note:
Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.